BioStock: Saniona’s new CBO on strategy and business development

Saniona has recruited Wendy Dwyer to the position of Chief Business Officer. BioStock reached out to Dwyer, who played a key role in securing an 815 million USD license agreement with 85 million USD upfront for a preclinical immuno-oncology asset at Surface Oncology Inc. We also learn how she thinks business development can create value at Saniona and what her priorities will be during the coming year. 

Read the full interview with Wendy Dwyer at biostock.se:

https://www.biostock.se/en/2021/09/sanionas-new-cbo-on-strategy-and-business-development/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se